Symbols / CALC Stock $0.62 +3.47% CalciMedica, Inc.

Healthcare • Biotechnology • United States • NCM
CALC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. A. Rachel Leheny Ph.D.
Exch · Country NCM · United States
Market Cap 9.80M
Enterprise Value 6.48M
Income -29.56M
Sales —
FCF (ttm) -13.02M
Book/sh -0.43
Cash/sh 0.83
Employees 16
Insider 10d —
IPO Jun 14, 2023
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.38
PEG —
P/S —
P/B -1.45
P/C —
EV/EBITDA -0.28
EV/Sales —
Quick Ratio 3.44
Current Ratio 3.58
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.97
EPS next Y -1.63
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-03
Earnings (prior) 2026-03-03
ROA -86.57%
ROE -7.61%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 15.75M
Shs Float 9.11M
Insider Own 21.61%
Instit Own 40.64%
Short Float 3.34%
Short Ratio 1.49
Short Interest 372.16K
52W High 7.20
vs 52W High -91.36%
52W Low 0.46
vs 52W Low 35.01%
Beta 1.03
Impl. Vol. 12.50%
Rel Volume 0.22
Avg Volume 329.70K
Volume 72.59K
Target (mean) $10.33
Tgt Median $10.00
Tgt Low $6.00
Tgt High $15.00
# Analysts 3
Recom None
Prev Close $0.60
Price $0.62
Change 3.47%
About

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.33
Mean price target
2. Current target
$0.62
Latest analyst target
3. DCF / Fair value
$-14.88
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.62
Low
$6.00
High
$15.00
Mean
$10.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-05 main Oppenheimer Outperform → Outperform $10
2026-01-29 down HC Wainwright & Co. Buy → Neutral —
2025-05-15 reit HC Wainwright & Co. Buy → Buy $16
2025-04-01 reit HC Wainwright & Co. Buy → Buy $16
2025-03-04 reit HC Wainwright & Co. Buy → Buy $16
2024-12-17 init LUCID CAPITAL MARKETS — → Buy $13
2024-11-14 reit HC Wainwright & Co. Buy → Buy $16
2024-11-04 main HC Wainwright & Co. Buy → Buy $16
2024-08-13 reit HC Wainwright & Co. Buy → Buy $20
2024-07-10 main Oppenheimer Outperform → Outperform $20
2024-07-09 reit HC Wainwright & Co. Buy → Buy $20
2024-06-27 reit HC Wainwright & Co. Buy → Buy $20
2024-05-14 reit HC Wainwright & Co. Buy → Buy $20
2024-04-01 main Oppenheimer Outperform → Outperform $14
2024-04-01 reit HC Wainwright & Co. Buy → Buy $20
2024-03-13 reit HC Wainwright & Co. Buy → Buy $20
2024-02-16 init JonesTrading — → Buy $22
2024-02-13 reit HC Wainwright & Co. Buy → Buy $20
2024-01-29 init HC Wainwright & Co. — → Buy $20
2023-11-13 reit Oppenheimer Outperform → Outperform $14
News
RSS: Latest CALC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-18 ROBERTS ERIC W Officer, Director and Beneficial Owner — 2,500 $3.07 $7,675
2025-09-15 ROBERTS ERIC W Officer, Director and Beneficial Owner — 3,400 $2.68 $9,105
2025-09-12 ROBERTS ERIC W Officer, Director and Beneficial Owner — 5,000 $3.12 $15,600
2025-09-09 ROBERTS ERIC W Officer, Director and Beneficial Owner — 2,343 $3.15 $7,378
2025-08-29 ROBERTS ERIC W Officer, Director and Beneficial Owner — 10,000 $2.74 $28,532
2025-08-21 ROBERTS ERIC W Officer, Director and Beneficial Owner — 3,508 $2.79 $9,797
2025-08-20 ROBERTS ERIC W Officer, Director and Beneficial Owner — 3,000 $2.72 $8,230
2025-08-20 ROBERTS ERIC W Officer, Director and Beneficial Owner — 15,000 $1.53 $22,950
2025-08-19 HEBBAR SUDARSHAN Officer — 9,563 $2.82 $26,962
2025-08-15 ROBERTS ERIC W Officer, Director and Beneficial Owner — 5,076 $2.90 $14,709
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
23.12
-4.47%
24.20
-36.43%
38.08
+168.27%
14.19
Research And Development
15.23
+5.22%
14.48
-8.71%
15.86
+89.93%
8.35
Selling General And Administration
7.89
-18.91%
9.73
-56.22%
22.22
+280.22%
5.84
General And Administrative Expense
7.89
-18.91%
9.73
-56.22%
22.22
+280.22%
5.84
Salaries And Wages
4.38
+13.30%
3.86
-77.10%
16.87
+638.38%
2.29
Other Gand A
3.51
-40.14%
5.86
+9.69%
5.34
+50.20%
3.56
Total Expenses
23.12
-4.47%
24.20
-36.43%
38.08
+168.27%
14.19
Operating Income
-23.12
+4.47%
-24.20
+36.43%
-38.08
-168.27%
-14.19
Total Operating Income As Reported
-23.12
+4.47%
-24.20
+36.43%
-38.08
-168.27%
-14.19
EBITDA
-28.09
-105.94%
-13.64
+64.12%
-38.02
-397.60%
-7.64
Normalized EBITDA
-22.09
+4.49%
-23.13
+43.83%
-41.19
-190.67%
-14.17
Reconciled Depreciation
0.05
-20.69%
0.06
+0.00%
0.06
+11.54%
0.05
EBIT
-28.14
-105.40%
-13.70
+64.02%
-38.08
-394.99%
-7.69
Total Unusual Items
-6.00
-163.22%
9.49
+199.56%
3.17
-51.48%
6.53
Total Unusual Items Excluding Goodwill
-6.00
-163.22%
9.49
+199.56%
3.17
-51.48%
6.53
Special Income Charges
—
—
—
-2.96
Impairment Of Capital Assets
—
—
—
0.00
Restructuring And Mergern Acquisition
—
—
—
2.96
Write Off
—
—
—
—
Net Income
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Pretax Income
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Net Non Operating Interest Income Expense
-0.71
-169.92%
1.01
+1021.82%
-0.11
+16.67%
-0.13
Interest Expense Non Operating
1.42
0.00
-100.00%
0.11
-16.67%
0.13
Net Interest Income
-0.71
-169.92%
1.01
+1021.82%
-0.11
+16.67%
-0.13
Interest Expense
1.42
0.00
-100.00%
0.11
-16.67%
0.13
Interest Income Non Operating
0.71
-29.68%
1.01
—
0.57
Interest Income
0.71
-29.68%
1.01
—
0.57
Other Income Expense
-5.73
-160.40%
9.49
+155.24%
3.72
-42.81%
6.50
Other Non Operating Income Expenses
0.27
-73.57%
1.01
+84.36%
0.55
+2064.29%
-0.03
Gain On Sale Of Security
-6.00
-163.22%
9.49
+199.56%
3.17
-51.48%
6.53
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Net Income From Continuing Operation Net Minority Interest
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Net Income From Continuing And Discontinued Operation
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Net Income Continuous Operations
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Normalized Income
-23.56
-1.60%
-23.19
+38.20%
-37.52
-161.44%
-14.35
Net Income Common Stockholders
-29.56
-115.78%
-13.70
+60.12%
-34.36
-275.81%
-9.14
Otherunder Preferred Stock Dividend
—
—
0.00
-100.00%
1.32
Diluted EPS
—
-1.22
+84.07%
-7.66
+93.11%
-111.16
Basic EPS
—
-1.22
+84.07%
-7.66
+93.11%
-111.16
Basic Average Shares
—
11.25
+150.67%
4.49
+5354.75%
0.08
Diluted Average Shares
—
11.25
+150.67%
4.49
+5354.75%
0.08
Diluted NI Availto Com Stockholders
-29.56
-115.78%
-13.70
+60.12%
-34.36
-275.81%
-9.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
13.59
-31.34%
19.79
+62.45%
12.19
+263.84%
3.35
Current Assets
13.53
-31.20%
19.66
+69.45%
11.61
+570.81%
1.73
Cash Cash Equivalents And Short Term Investments
13.02
-30.28%
18.67
+66.12%
11.24
+746.87%
1.33
Cash And Cash Equivalents
11.52
+45.18%
7.93
+43.49%
5.53
+316.73%
1.33
Other Short Term Investments
1.50
-86.06%
10.73
+88.05%
5.71
0.00
Receivables
—
—
—
0.04
Accrued Interest Receivable
—
—
—
0.04
Prepaid Assets
0.20
-73.13%
0.75
+953.52%
0.07
-85.88%
0.50
Restricted Cash
—
—
0.00
-100.00%
0.15
Assets Held For Sale Current
0.05
0.00
—
—
Other Current Assets
0.26
+4.44%
0.25
-16.22%
0.30
+16.54%
0.25
Total Non Current Assets
0.06
-52.71%
0.13
-77.76%
0.58
-64.18%
1.62
Net PPE
0.05
-57.98%
0.12
-28.74%
0.17
-14.36%
0.20
Gross PPE
0.05
-57.98%
0.12
-28.74%
0.17
-14.36%
0.20
Accumulated Depreciation
—
—
—
0.00
Properties
—
—
—
0.00
Machinery Furniture Equipment
—
—
—
0.00
Construction In Progress
—
—
—
0.00
Other Properties
0.05
-57.98%
0.12
-28.74%
0.17
-14.36%
0.20
Leases
—
—
—
0.00
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
0.01
+10.00%
0.01
-97.58%
0.41
-71.00%
1.42
Total Liabilities Net Minority Interest
20.23
+275.78%
5.38
+33.66%
4.03
-67.99%
12.58
Current Liabilities
3.78
+2.66%
3.68
-8.54%
4.03
-15.73%
4.78
Payables And Accrued Expenses
2.53
-31.27%
3.68
-6.47%
3.94
-14.01%
4.58
Payables
1.16
-41.89%
2.00
+40.80%
1.42
-50.52%
2.87
Accounts Payable
1.16
-41.89%
2.00
+40.80%
1.42
-50.49%
2.87
Current Accrued Expenses
1.37
-18.68%
1.69
-33.10%
2.52
+47.11%
1.71
Pensionand Other Post Retirement Benefit Plans Current
—
0.00
-100.00%
0.09
0.00
Total Tax Payable
—
—
0.08
+3750.00%
0.00
Current Debt And Capital Lease Obligation
1.25
—
—
0.20
Current Debt
1.25
—
—
—
Other Current Borrowings
1.25
—
—
—
Current Capital Lease Obligation
—
—
—
0.20
Current Deferred Liabilities
—
—
—
0.00
Other Current Liabilities
—
—
—
0.20
Total Non Current Liabilities Net Minority Interest
16.45
+867.65%
1.70
0.00
-100.00%
7.80
Long Term Debt And Capital Lease Obligation
8.45
—
—
5.16
Long Term Debt
8.45
—
—
5.16
Non Current Deferred Liabilities
—
—
—
0.00
Stockholders Equity
-6.64
-146.09%
14.41
+76.66%
8.16
+188.35%
-9.23
Common Stock Equity
-6.64
-146.09%
14.41
+76.66%
8.16
+111.44%
-71.30
Capital Stock
0.00
+0.00%
0.00
+300.00%
0.00
-100.00%
62.07
Common Stock
0.00
+0.00%
0.00
+300.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
-100.00%
62.07
Share Issued
15.44
+14.50%
13.48
+134.28%
5.75
+271.32%
1.55
Ordinary Shares Number
15.44
+14.50%
13.48
+134.28%
5.75
+271.32%
1.55
Additional Paid In Capital
182.68
+4.89%
174.17
+12.93%
154.22
+281.71%
40.40
Retained Earnings
-189.33
-18.50%
-159.76
-9.38%
-146.06
-30.76%
-111.71
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
0.00
+100.00%
0.00
+105.41%
-0.04
Other Equity Adjustments
—
0.00
+100.00%
0.00
+105.41%
-0.04
Total Equity Gross Minority Interest
-6.64
-146.09%
14.41
+76.66%
8.16
+188.35%
-9.23
Total Capitalization
1.81
-87.45%
14.41
+76.66%
8.16
+300.12%
-4.08
Working Capital
9.75
-39.00%
15.98
+110.91%
7.58
+348.43%
-3.05
Invested Capital
3.06
-78.77%
14.41
+76.66%
8.16
+112.33%
-66.15
Total Debt
9.70
—
—
5.16
Net Debt
—
—
—
3.83
Capital Lease Obligations
—
—
—
0.20
Net Tangible Assets
-6.64
-146.09%
14.41
+76.66%
8.16
+188.35%
-9.23
Tangible Book Value
-6.64
-146.09%
14.41
+76.66%
8.16
+111.44%
-71.30
Derivative Product Liabilities
8.00
+370.59%
1.70
0.00
-100.00%
2.65
Preferred Stock Equity
—
—
—
62.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-21.18
-0.15%
-21.15
+17.82%
-25.73
-118.85%
-11.76
Cash Flow From Continuing Operating Activities
-21.18
-0.15%
-21.15
+17.82%
-25.73
-118.85%
-11.76
Net Income From Continuing Operations
-29.56
-115.78%
-13.70
+60.12%
-34.36
-339.12%
-7.82
Depreciation Amortization Depletion
0.05
-20.69%
0.06
+0.00%
0.06
+11.54%
0.05
Depreciation
0.05
-20.69%
0.06
+0.00%
0.06
-82.84%
0.34
Depreciation And Amortization
0.05
-20.69%
0.06
+0.00%
0.06
+11.54%
0.05
Other Non Cash Items
0.34
—
0.11
-16.67%
0.13
Stock Based Compensation
2.97
+28.45%
2.31
-80.79%
12.04
+566.24%
1.81
Asset Impairment Charge
—
—
—
1.60
Operating Gains Losses
5.22
+159.94%
-8.71
-660.38%
-1.15
+69.71%
-3.78
Gain Loss On Investment Securities
5.22
+159.94%
-8.71
-660.38%
-1.15
+69.71%
-3.78
Unrealized Gain Loss On Investment Securities
0.78
0.00
+100.00%
-2.02
+26.34%
-2.75
Change In Working Capital
-0.62
-25.86%
-0.49
-85.39%
-0.27
-144.13%
0.60
Change In Prepaid Assets
0.54
+335.09%
-0.23
-107.61%
3.00
+295.88%
-1.53
Change In Payables And Accrued Expense
-1.16
-334.08%
-0.27
+91.82%
-3.26
-252.88%
2.13
Change In Accrued Expense
-0.32
+63.25%
-0.87
+52.75%
-1.84
-252.83%
1.20
Change In Payable
-0.84
-239.77%
0.60
+142.12%
-1.43
-252.95%
0.93
Change In Account Payable
-0.84
-239.77%
0.60
+142.12%
-1.43
-252.95%
0.93
Change In Other Current Liabilities
—
—
—
-2.27
Investing Cash Flow
9.55
+315.94%
-4.42
-149.79%
8.88
+222200.00%
-0.00
Cash Flow From Continuing Investing Activities
9.55
+315.94%
-4.42
-149.79%
8.88
+222200.00%
-0.00
Net PPE Purchase And Sale
-0.03
-250.00%
-0.01
+89.74%
-0.08
-1850.00%
-0.00
Purchase Of PPE
-0.03
-250.00%
-0.01
+89.74%
-0.08
-1850.00%
-0.00
Sale Of PPE
—
—
—
0.43
Capital Expenditure
-0.03
-250.00%
-0.01
+89.74%
-0.08
-1850.00%
-0.00
Net Investment Purchase And Sale
9.58
+316.96%
-4.42
-149.26%
8.96
0.00
Purchase Of Investment
-15.92
+45.12%
-29.00
-374.04%
-6.12
0.00
Sale Of Investment
25.50
+3.69%
24.59
+63.04%
15.08
0.00
Net Intangibles Purchase And Sale
—
—
—
-1.94
Purchase Of Intangibles
—
—
—
-1.94
Financing Cash Flow
15.21
-45.62%
27.97
+33.85%
20.90
+146.58%
8.48
Cash Flow From Continuing Financing Activities
15.21
-45.62%
27.97
+33.85%
20.90
+146.58%
8.48
Net Issuance Payments Of Debt
9.66
0.00
0.00
-100.00%
8.46
Issuance Of Debt
9.66
0.00
0.00
-100.00%
8.46
Long Term Debt Issuance
9.66
0.00
0.00
-100.00%
8.46
Net Long Term Debt Issuance
9.66
0.00
0.00
-100.00%
8.46
Net Common Stock Issuance
5.52
-80.24%
27.95
+9.86%
25.45
+141261.11%
0.02
Proceeds From Stock Option Exercised
0.03
+25.00%
0.02
0.00
0.00
Net Other Financing Charges
—
—
-4.54
-3169.78%
-0.14
Changes In Cash
3.58
+49.06%
2.40
-40.68%
4.05
+223.41%
-3.29
Beginning Cash Position
7.93
+43.49%
5.53
+274.66%
1.48
-69.00%
4.76
End Cash Position
11.52
+45.18%
7.93
+43.49%
5.53
+274.66%
1.48
Free Cash Flow
-21.21
-0.25%
-21.15
+18.03%
-25.81
-119.44%
-11.76
Interest Paid Supplemental Data
1.09
0.00
—
—
Amortization Of Securities
-0.34
+43.26%
-0.61
-319.31%
-0.14
0.00
Common Stock Issuance
5.52
-80.24%
27.95
+9.86%
25.45
+141261.11%
0.02
Issuance Of Capital Stock
5.52
-80.24%
27.95
+9.86%
25.45
+141261.11%
0.02
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category